Results per Page:
Menopausal hormone therapy may lower the risk of colorectal cancer
From the Peters and Hsu Groups, Cancer Consortium & Public Health Sciences Division
Fred Hutch and UW hematology-oncology fellows win ASCO Young Investigator Awards
Winners represent broad range of research
New prostate cancer cell lines shed light on CRPC
From the Haffner Lab, Human Biology Division
The association between postmenopausal hormone therapy and colorectal cancer by subtype and location
From the Labadie Group and Newcomb Group
Your post-cancer treatment sex Rx
Expert tips, tools and tricks to help you reboot your post-cancer body and rekindle intimacy after cancer treatment
Fred Hutch researchers tackle hot flashes
New study finds antidepressant nearly as effective as low-dose estrogen for cutting back hot flash frequency
Intermittent hormone therapy for prostate cancer inferior to continuous therapy
Cathy Tangen contributes to international study, finding on again-off again prostate cancer treatment has quality of life benefits, but continuous therapy improves overall survival
PET scans confirm effectiveness of estrogen-blocking therapy
SCCA study findings have implications for personalized breast cancer treatment and drug development
Postmenopausal estrogen use brings both benefits, risks
Longer-term Women’s Health Initiative follow-up of estrogen therapy users finds reduced risk of breast cancer, decreased heart disease in younger women
Combined hormone therapy increases risk of lobular breast cancer fourfold after just three years of use
Center leads first study designed to evaluate the association between combined HRT use and the risk of lobular breast cancers
Long-Term Smoking is Associated With Up to 40 Percent Increased Risk of Breast Cancer
Combination HRT appears to more than double the risk in women who smoke